HC Wainwright & Co. Reiterates Buy on Mustang Bio, Maintains $25 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Mustang Bio (NASDAQ:MBIO) and maintained a $25 price target.
August 15, 2023 | 10:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mustang Bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $25.
The reiteration of a 'Buy' rating and a maintained price target by a reputable analyst firm like HC Wainwright & Co. is a positive signal for Mustang Bio. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100